단일색상

(Blister Balm)/Health Care/Medications Treatments/DIRECT FROM USA/BLISTER BALM Protective Cold Sore Fever Blister Prevention Treatment For Everyday Use ? 50x S...


Studio : Blister Balm

Publisher : Blister Balm

Binding : Health and Beauty

Product Description
Why use a product containing synthetic ingredients when you can use something more effective that is ALSO 100% natural? Blister Balm Protective Lip Treatment is designed to help reduce the frequency of outbreaks and is especially effective when used daily or during periods of stress, exposure to heat or cold or sunlight, or during other periods known to trigger outbreaks of the HSV-1 virus. Our patented essential ingredient, outperforms the active ingredient used in Abreva*, the leading cold sore medication. How Is It More Effective Than Products Currently Available? When the jojoba molecule is divided, almost ½ of the resulting components are comprised of an array of more than a dozen different C-16 through C-26 fatty alcohols. The active ingredient in Abreva* is a synthetic version of a C-22 fatty alcohol known as docosanol. The combination of a dozen or more natural fatty alcohols in Blister Balm essentially TRIPLES the amount of these essential ingredients available in the Protective Lip Treatment to safely fight the development of cold sores and fever blisters. The Science Behind It Jojoba is a native shrub found growing wild among the hillsides of the Sonora Desert of Arizona, Southern California and Mexico. Scientists in the Sonora Desert have isolated a fraction of the liquid wax found in the seed of the jojoba plant and have determined that this fraction is more effective in treating the HSV-1 virus (Herpes Simplex) which causes Cold Sores and Fever Blisters, than the synthetic docosanol used in Abreva*. This fraction isolated from the jojoba seed consists of more than a dozen naturally occurring long chain fatty alcohols with carbon chain lengths of C-16 through C-26 and according to in-vitro independent laboratory studies, has been determined to be 50 times stronger in fighting the virus cells than the synthetic active ingredient in Abreva*. *Abreva is a registered trademark of the Glaxo Smith Kline Company
0